Trial Profile
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Antineoplastics
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms PROSKIN
- 27 Mar 2009 New trial record
- 27 Mar 2009 New trial record